ClearPoint Neuro financials
$11.77−23.12%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.9M | $12.1M | $10.4M | $8.9M | $9.2M | $8.5M | $7.8M | $8.1M | $7.9M | $7.6M | $6.8M | $5.8M |
| Gross profit | $6.7M | $7.8M | $6.4M | $5.6M | $5.6M | $5.1M | $4.8M | $4.8M | $5.0M | $4.5M | $4.0M | $3.3M |
| Gross margin | 61.7% | 64.0% | 61.5% | 63.2% | 60.3% | 60.5% | 61.3% | 59.7% | 63.5% | 59.2% | 58.9% | 56.8% |
| Operating income | -$10.2M | -$8.5M | -$7.0M | -$5.3M | -$5.7M | -$6.2M | -$5.6M | -$5.2M | -$4.7M | -$4.2M | -$4.7M | -$4.9M |
| Net income | -$11.3M | -$9.6M | -$7.8M | -$5.9M | -$5.8M | -$6.0M | -$5.4M | -$5.0M | -$4.4M | -$4.1M | -$4.6M | -$4.8M |
| Net margin | −104.2% | −78.8% | −74.8% | −66.5% | −63.3% | −71.0% | −69.3% | −61.2% | −56.1% | −54.3% | −67.8% | −83.5% |
| Diluted EPS | $-0.38 | $-0.32 | $-0.27 | $-0.21 | $-0.21 | $-0.22 | $-0.20 | $-0.18 | $-0.16 | $-0.16 | $-0.19 | $-0.20 |
| EBITDA | -$8.9M | -$7.4M | -$6.2M | -$4.8M | -$5.1M | -$5.8M | -$5.2M | -$4.7M | -$4.3M | -$3.7M | -$4.7M | -$4.5M |
| Operating cash flow | -$7.0M | -$8.0M | -$12.1M | -$3.1M | -$2.6M | -$6.2M | -$1.2M | -$1.2M | -$2.7M | -$3.8M | -$1.2M | -$1.8M |
| Free cash flow | -$7.2M | -$8.6M | -$12.1M | -$3.3M | -$2.6M | -$6.4M | -$1.5M | -$1.2M | -$2.7M | -$3.8M | -$1.2M | -$2.0M |
| Diluted shares | 30.2M | 29.5M | 28.9M | 28.4M | 28.3M | 27.7M | 27.6M | 27.6M | 27.5M | 25.5M | 24.6M | 24.6M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $29.4M | $35.6M | $45.9M | $38.2M | $41.5M | $12.4M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $50.2M | $49.6M | $49.1M | $29.2M | $28.8M | $0.00 |
| Total assets | $86.7M | $93.4M | $97.7M | $60.4M | $62.9M | $30.1M |
| Total liabilities | $76.0M | $74.6M | $69.7M | $44.5M | $43.1M | $10.1M |
| Shareholders' equity | $10.8M | $18.8M | $28.0M | $15.9M | $19.7M | $20.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology